B
Brian Cox
Researcher at University of Sussex
Publications - 123
Citations - 2636
Brian Cox is an academic researcher from University of Sussex. The author has contributed to research in topics: Catalysis & Squalene. The author has an hindex of 27, co-authored 122 publications receiving 2479 citations. Previous affiliations of Brian Cox include The Hertz Corporation & University of Bristol.
Papers
More filters
Journal ArticleDOI
Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.
Martin J. Main,Jennifer Elizabeth GlaxoSmithKline Cryan,Joe R. B. Dupere,Brian Cox,Jeffrey J. Clare,Stephen Anthony Burbidge +5 more
TL;DR: It is shown that retigabine acts as a KCNQ potassium channel opener, and it is likely that M-current modulation can explain the anticonvulsant actions of retIGabine in animal models of epilepsy.
Journal ArticleDOI
New Heteroannulation Reactions of N-Alkoxybenzamides by Pd(II) Catalyzed C-H Activation
TL;DR: A new palladium(II) catalyzed methodology for the direct synthesis of alkylidene isoindolinones from N-alkoxybenzamides is presented and both systems were found to tolerate a wide range of functionality.
Journal ArticleDOI
Batch versus Flow Photochemistry: A Revealing Comparison of Yield and Productivity
Luke D. Elliott,Jonathan P. Knowles,Paul J. Koovits,Katie G. Maskill,Michael J. Ralph,Guillaume Lejeune,Lee Edwards,Richard I. Robinson,Ian Clemens,Brian Cox,David D. Pascoe,Guido Koch,Martin Eberle,Malcolm B. Berry,Kevin I. Booker-Milburn +14 more
TL;DR: A broad range of synthetic photochemical transformations were optimized in both reactor modes and their yields and productivities compared and it was revealed that the productivity of flow reactors varied very little to that of their batch counterparts when the key reaction parameters were matched.
Journal ArticleDOI
HTS approaches to voltage-gated ion channel drug discovery
TL;DR: The authors describe the current technologies available for voltage-gated ion-channel screening, their application to HTS campaigns and the current limitations and emerging technologies within this area.
Journal ArticleDOI
Drug block of the hERG potassium channel: Insight from modeling
Phillip J. Stansfeld,Peter Gedeck,Martin Gosling,Brian Cox,John S. Mitcheson,Michael J. Sutcliffe +5 more
TL;DR: A KcsA‐based model was refined by rotating the four copies of the S6 transmembrane helix half a residue position toward the C‐terminus, so as to place all residues known to be involved in drug binding in positions lining the central cavity to produce complexes that are consistent with mutagenesis data for smaller, but not larger, ligands.